Day: April 24, 2020

VANCOUVER, British Columbia, April 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“syarikat” atau “Algernon”) sebuah syarikat pembangunan farmaseutikal peringkat klinikal, dengan sukacita mengumumkan bahawa mereka telah menerima kelulusan daripada Kementerian Keselamatan Makanan dan Ubat di Korea Selatan, serta kelulusan etika untuk kajian klinikal COVID-19 Fasa 2 yang diketuai oleh penyelidik, untuk ubat NP-120 (Ifenprodil) yang diubah tujuan, yang merupakan antagonis reseptor NMDA.Ketua Penyelidik Utama ialah Dr. Dong Sik Jung, Profesor, dalam Bahagian Penyakit Berjangkit di Hospital Universiti Dong-A, Busan.Percubaan selama 4 minggu untuk 40 pesakit ini direka bentuk untuk menguji kesan Ifenprodil dalam pesakit yang dijangkiti COVID-19 dengan pneumonia yang teruk. Pesakit...

캐나다 밴쿠버, April 24, 2020 (GLOBE NEWSWIRE) — 임상 단계 제약 개발사인 Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF)는 대한민국 식품의약품안전처로부터 NMDA 수용체 길항제로 당사가 약물 재창출 방식으로 개발 중인 NP-120(이펜프로딜)에 대한 코로나19(COVID-19) 연구자 주도 임상2상 연구에 대한 규제기관 및 윤리적 승인을 획득했다고 밝혔다.이번 연구의 주연구자는 부산 동아대병원 감염관리실장인 정동식 교수다.40명의 환자를 대상으로 4주에 걸쳐 실시되는 임상은 코로나19 감염 중증 폐렴 환자를 대상으로 이펜프로딜의 효능을 살펴보는 시험이다. 환자들은 시험군과 대조군으로 1:1 무작위 배정되어 표준치료제(SOC) 혹은 SOC와 이펜프로딜을 함께 투여받는다. 1차 평가변수는 혈액 산소 농도 측정(Pa02/Fi02)을 통한 폐 기능 향상 여부 측정이다. 2차 평가변수는 사망률, 기계적 인공호흡, 환자가 보고한 기침 및 숨 가쁨(호흡장애)에 대한 효과가 포함된다.임상2상 환자 모집은 2020년 5월 8일부터 시작될 예정이다.크리스토퍼 모로(Christopher J. Moreau) Algernon Pharmaceuticals CEO는 “코로나19에 대한 이펜프로딜의 첫 인간 대상 시험은 우리 회사의 새로운 급성 폐손상 임상 연구 프로그램이 거둔 중대한 성과”라면서 “우리 회사는 이펜프로딜의 코로나19 치료제 가능성을 지속적으로 연구해 왔다. 그런 만큼 긍정적인 방향으로 임상2상 데이터가 도출될 경우 기념비적인 일이 될 것이다. 또한 우리 회사의...

Selskabsmeddelelse nr. 2020/08I forlængelse af selskabsmeddelelse nr. 6 af 20. marts 2020, hvor forventningerne til årets resultat i 2020 blev suspenderet pga. COVID-19, offentliggøres hermed bankens resultatet for 1. kvartal 2020.Resultatet efter skat for 1. kvartal 2020 på minus 17,1 mio. kr. er negativt påvirket af effekterne af COVID-19 primært for så vidt angår kursreguleringer og nedskrivninger. Netto rente- og gebyrindtægter er på niveau med ledelsens budgetterede forventning. Omkostningerne til personale og administration er ca. 5 pct. lavere end de budgetterede forventninger.Kursreguleringer og nedskrivningerKursreguleringer udgør minus 10,1 mio.kr., hvor af kursreguleringen af bankens handelsbeholdning af obligationer og aktier udgør minus 14,6 mio.kr.Nedskrivninger udgør 20,1 mio.kr. Bogførte nedskrivninger som følge af COVID-19...

The annual general meeting of Sbanken ASA was held 24 April 2020. All proposals on the agenda were approved, including the Board of Directors’ revised recommendation that dividend for 2019 not be distributed at this point in time.The minutes from the Annual General Meeting are attached.Contact details,Jesper M. Hatletveit, Head of IR, Sbanken ASA, +47 959 40 045Henning Nordgulen, CFO, Sbanken ASA, +47 952 65 990This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentMinutes Sbanken ASA Annual General Meeting 2020

Ordinær generalforsamling i Sbanken ASA ble avholdt den 24. april 2020. Alle forslag på agendaen ble vedtatt, inklusiv styrets reviderte anbefaling om på nåværende tidspunkt å ikke utbetale utbytte for regnskapsåret 2019.Protokollen fra ordinær generalforsamling er vedlagt.Kontaktinformasjon:Jesper M. Hatletveit, Investor Relations, Sbanken ASA, +47 959 40 045Henning Nordgulen, CFO, Sbanken ASA, +47 952 65 990Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12VedleggProtokoll Sbanken ASA generalforsamling 2020

ROLLING MEADOWS, Ill., April 24, 2020 (GLOBE NEWSWIRE) — Cambium Networks Corporation (“Cambium Networks”) (NASDAQ: CMBM), a leading provider of wireless networking infrastructure solutions, today announced that it plans to report financial results for the first quarter 2020 ended March 31, 2020 on Tuesday, May 12, 2020.Cambium Networks will host a webcast and conference call to discuss its financial results and Q&A at 4:30 p.m. ET/1:30 p.m. PT on Tuesday May 12, 2020. On the call will be Atul Bhatnagar, president and CEO, and Stephen Cumming, CFO. The call will be moderated by Peter Schuman, senior director of investor & industry analyst relations.To join the financial results live webcast and view additional materials which may be posted to the investor website, listeners should access the investor page of Cambium Networks...

Press Release      April 24, 2020 – N° 9SCOR welcomes Fitch’s decision to confirm itsInsurer Financial Strength Rating of ‘AA-’and outlook as stableSCOR has been informed of Fitch’s decision to affirm the Group’s Financial Strength Rating of ‘AA-‘ (Very Strong) and Long-Term Issuer Default Rating (IDR) at ‘A+’. Fitch has also affirmed the ratings of SCOR’s core operating subsidiaries. The Outlooks are Stable.According to Fitch, this decision reflects “Fitch’s current assessment of the impact of the coronavirus pandemic, including its economic impact, under a set of rating assumptions.”Fitch assesses “SCOR’s capitalisation and leverage as very strong”, both in their “rating and stress cases and versus the last two years. Fitch does not foresee a material weakening of SCOR’s capital strength in the medium-term, assuming...

Communiqué de presse24 avril 2020 – N° 9SCOR salue la décision de Fitch de confirmer la note de solidité financière du Groupe à « AA- » et sa perspective à « stable »Le Groupe SCOR a été informé de la décision de l’agence de notation Fitch de confirmer sa note de solidité financière à « AA- » (très forte), ainsi que sa note de crédit émetteur à « A+ ». Fitch a également affirmé les notes des filiales opérationnelles de SCOR. Ces notations ont une perspective stable.Selon Fitch, cette décision reflète son « appréciation actuelle de l’impact de la pandémie de coronavirus, y compris son impact économique, sur la base d’un ensemble d’hypothèses ».Fitch considère « le critère de ‘capitalisation et endettement‘ de SCOR comme étant à un niveau très élevé », à la fois « dans un scénario central et dans un scénario de stress et par rapport...

ASIAKASTIETO GROUP PLC, INVESTOR NEWS 24 APRIL 2020 AT 1.15 P.M. EESTAsiakastieto Group will publish January – March Interim Report on 8 May 2020Asiakastieto Group Plc will publish its Interim Report 1.1. – 31.3.2020 on Friday, 8 May 2020 at 11.00 a.m. EEST. The Interim Report will be available on Asiakastieto’s investor website https://investors.asiakastieto.fi/ after publication.Asiakastieto Group will hold a webcast for analysts, investors and media in English on the same day, where CEO Jukka Ruuska and CFO Elina Stråhlman will present the performance and events of the first quarter 2020.Date and time: Friday, 8 May 2020 at 2.00 p.m. EESTYou can follow the English webcast and conference call at:https://cloud.webcast.fi/asiakastieto/asiakastieto_2020_0508_q1/To participate in the conference call, please dial in using one of the numbers...

ASIAKASTIETO GROUP OYJ, SIJOITTAJAUUTINEN 24.4.2020 KLO 13.15Asiakastieto Group julkaisee tammi – maaliskuun osavuosikatsauksen 8.5.2020Asiakastieto Group Oyj:n osavuosikatsaus 1.1. – 31.3.2020 julkaistaan perjantaina 8.5.2020 klo 11.00. Osavuosikatsaus on saatavilla julkaisun jälkeen Asiakastiedon sijoittajasivuilla osoitteessa https://investors.asiakastieto.fi/?lang=fiAsiakastieto Group järjestää samana päivänä analyytikoille, sijoittajille ja toimittajille englanninkielisen webcast-lähetyksen, jossa toimitusjohtaja Jukka Ruuska ja talousjohtaja Elina Stråhlman esittelevät ensimmäisen vuosineljänneksen tapahtumia ja tuloskehitystä.Päivä ja aika: Perjantai 8.5.2020 klo 14.00Englanninkielistä webcast-lähetystä ja puhelinkonferenssia voitte seurata osoitteessa: https://cloud.webcast.fi/asiakastieto/asiakastieto_2020_0508_q1/Puhelinkonferenssiin...